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Abstract
Leber hereditary optic neuropathy (LHON) is a genetic condition that typically presents with
unilateral, painless, sub-acute central vision loss followed by contralateral vision loss after a
few weeks to months. It is a rare disease that typically affects young adults - men more than
women - and is a relatively common cause of blindness. It is due to a mutation in
mitochondrial DNA (mtDNA). The majority (more than 95%) of patients have one of three
mtDNA point mutations: m.14484T→C, m.3460G→A, or m.11778G→A. These mutations lead to
disruption of the mitochondrial respiratory chain activating pro-apoptotic pathways. For
reasons unknown, this insult tends to affect the retinal ganglion cells more than any other cell
in the body, leading to the disease state. Due to its low prevalence in the United States
(1:50,000), this diagnosis is often overlooked, misdiagnosed, and mismanaged, which may
exacerbate symptoms. It is essential then for physicians to recognize the presentation of and
understand the diagnostic work-up for LHON. In this case report, we present the diagnostic
challenges of a patient who presented with progressive vision loss, discuss the various
differential diagnoses, review the literature on LHON, and propose an explanatory model for
vision loss in patients with LHON.
Categories: Neurology, Ophthalmology, Allergy/Immunology
Keywords: leber hereditary optic neuropathy, optic neuropathy, mitochondrial dna mutation, vision
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Introduction
Leber hereditary optic neuropathy (LHON) is a genetic disorder that primarily involves
mitochondrial DNA (mtDNA), leading to mitochondrion dysfunction in the eye causing focal
degeneration of the retinal ganglion cell (RGC) layer in the retina and of the optic nerve. This is
associated with bilateral, acute-to-sub-acute, severe central vision loss, which normally
presents in one’s twenties and thirties, affecting more men than women [1]. The loss of vision
typically starts in one eye followed by contralateral vision loss after weeks or months. Up to
50% of affected patients do not have a family history of vision loss. Prognosis of the vision loss
is poor, and most of those living with the condition remain significantly visually impaired.
More than 9 in 10 patients with LHON suffer from either of three obvious causative mtDNA
mutations: m.14484T→C, m.3460G→A, or m.11778G→A [2]. Another intriguing aspect of LHON
genetics is that the associated mutations have incomplete penetrance. This means that not
everyone with one of these three mutations develops LHON despite the fact that more than
90% of patients with LHON have one of the aforementioned mutations. Clearly, mtDNA
mutation is not enough by itself to cause LHON. To that end, secondary modulators such as
factors related to nuclear genetics and the environment have been considered contributors [3].
This case study highlights the difficulty in diagnosing LHON and how it may masquerade as
other conditions if careful clinical analysis is not conducted, and discusses a possible trigger for
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LHON in patients with one of the three mutations.
Case Presentation
A 49-year-old Jamaican male presented with a recent history of vision loss. About three or four
months prior to his hospitalization, he suffered sudden-onset non-progressive decrease in
visual acuity of the left eye. Later that day, he experienced decreased vision in his right eye
followed by worsening vision of the left eye two days later. Approximately one week later, he
developed numbness in the plantar surface of his right foot and right calf followed by similar
symptoms in the left leg two weeks later. He was initially followed in the community as an
outpatient and was prescribed high-dose steroids for a suspected diagnosis of neuromyelitis
optica (NMO). The patient was also evaluated by an ophthalmologist who found increased
intraocular pressure and diagnosed him with glaucoma in the left eye. As symptoms progressed
despite outpatient treatment, he sought care at the Marcus Neuroscience Institute at Boca
Raton Regional Hospital for further evaluation and management. He had no other significant
medical or family history of vision loss.
In the Emergency Department, he was hemodynamically stable, with visual acuity of 20/200 in
the left eye and 20/70 in the right eye. Confrontational visual field testing showed a left upper
quadrant deficit in the left eye, with red dyschromatopsia and increased cup-to-disc ratio
doubled that of the right eye. Optokinetic flag testing was normal bilaterally. Computed
tomography (CT) scan of the head was unremarkable. A repeat magnetic resonance imaging
(MRI) of the brain, orbits, and C-spine was negative for demyelinating lesions, as seen in NMO
(Figure 1). A lumbar puncture was performed with cerebrospinal fluid (CSF) analysis showing
no oligoclonal banding at a dilution factor of 46, negative immunoglobulin G (IgG) index
(indicating no intracerebral IgG production), and negative cytology for viral or bacterial
etiology (Table 1). An inpatient ophthalmology consultation was obtained, which demonstrated
no evidence of optic neuritis and confirmed the diagnosis of glaucoma.
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FIGURE 1: MRI of the Orbits and the Head.
(A) Coronal, T2-weighted, high-resolution, short-tau-inversion-recovery MRI indicating an increased
signal in the left optic nerve (white arrow). (B) Coronal, contrast-enhanced, high-resolution, fat-
suppressed, T1-weighted image indicating mild hazy-enhancement of the left optic nerve (white
arrow). (C) Axial, fluid-attenuated, inversion recovery imaging indicates no abnormal lesions of the
white matter. (D) Sagittal, nonconstrast-enhanced, T1-weighted image indicating no lesions in the
corpus callosum, which is normal in caliber and shape (white arrows).
MRI, magnetic resonance imaging
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Variable Reference Range [4] Test
Glucose (fasting) (mg/dL) 50-75 84
Total protein (mg/dL) 5-55 46
Color Colorless Colorless
Turbidity Clear Clear
Nucleated cell count (per mm3) 0-5 3
Red blood cell count (per mm3) 0-5 1
Differential count (%)   
  Blasts 0 0
  Bands 0 0
  Neutrophils 0 12
  Lymphocytes 0–100 14
  Reactive or atypical
lymphocytes 0 0
  Monocytes 0–100 67
  Eosinophils 0 0
  Basophils 0 0
  Macrophages 0 0
Xanthochromia None None
 Venereal Disease Research
Laboratory test Nonreactive Nonreactive
Oligoclonal bands No banding seen in CSF concentrated bya factor of 80
No banding seen in CSF concentrated by
a factor of 56
Microbiology No microscopic, antibody, or biochemicaldetection
No viruses, fungi, or bacteria detected in
CSF
TABLE 1: CSF Analysis
CSF, cerebrospinal fluid
The patient was discharged and instructed to follow up with a neuro-ophthalmologist. On
examination, corrected acuity was 20/200 in both eyes. Color vision was 8/8 in the right eye and
7/8 in the left eye. There was a left afferent pupillary defect. On fundoscopic examination, the
optic nerve was sharp in both eyes, with mild-to-moderate temporal pallor in the right eye and
2020 Filatov et al. Cureus 12(4): e7745. DOI 10.7759/cureus.7745 4 of 7
severe temporal pallor in the left eye. The cup-to-disc ratio was 0.5 in the right eye and 0.8 in
the left eye. There was a central scotoma in both eyes. More specifically, the left eye was found
to have a superior field cut by Amsler grid, a type of central scotoma that is consistent with
optic neuropathy. Based on these findings, negative neuroimaging, and normal CSF analysis,
our patient was recommended to undergo genetic testing for LHON. It yielded a homoplasmic,
m.11778G→A LHON mutation.
Differential diagnoses
Neuromyelitis Optica Spectrum Disorder
NMO is an inflammatory disorder of the central nervous system, which, in most cases, presents
as optic myelitis and/or neuritis. Our patient was negative for autoantibody to aquaporin 4,
eliminating NMO from diagnostic consideration [5].
Muscular Dystrophy
He had no signs of muscle weakness or wasting, respiratory insufficiency, or cardiac
dysfunction that is usually seen in muscular dystrophy [6].
Infection
Lyme disease, mumps, measles, cat-scratch fever, syphilis, and herpes may cause optic
neuritis [7]. CSF analysis ruled-out viral, bacterial, or fungal infection.
Sarcoidosis
Sarcoidosis causes symptoms such as lacrimation, red eyes, blurred vision, reddish bumps on
the skin, kidney stone formation, swollen and painful joints, hepatomegaly, and nervous
system effects. Nervous system involvement includes meningitis, hearing loss, seizures,
depression, and dementia [7]. Our patient experienced numbness on the bottom of the right
foot and calf but no joint pain. The lack of multi-organ involvement ruled out sarcoidosis [8].
Isolated Optic Neuritis
Optic neuritis is an immune-mediated neurologic disorder that results in demyelination and
inflammation of the optic nerve. It may be isolated or be a symptom of multiple sclerosis or
NMO. The absence of pain on presentation and negative imaging precludes this diagnosis. [7].
The absence of oligoclonal bands (Table 1) and negative neuroimaging ruled out multiple
sclerosis [9].
Leber Hereditary Optic Neuropathy
LHON is known to cause subacute, painless, severe loss of vision in one eye, and it progresses
to loss of vision in a similar fashion as the other eye [7]. The patient’s symptoms began with
loss of vision in his left eye and progressed to involve the right eye. This diagnosis confirmed by
detection of m.11778G→A mutation on genetic analysis.
Discussion
LHON is mainly associated with painless, subacute loss of central vision, which is bilateral and
mostly occurs in young adult males. Carriers of any one of the three mutations linked to LHON
experience significant vision loss before they reach the fifth decade of life. This has been
observed in multiple studies, including various populations from around the world [10]. Our
patient exemplifies the typical disease course of individuals with LHON. However, the question
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remains: what is the trigger for vision loss in this otherwise healthy male 11778G→A mutation
carrier? We propose that the most likely explanation is that raised intraocular pressure
triggered LHON conversion from dormant to active disease, leading to vision loss. Mitochondria
frequently crowd the optic nerve as the ganglion cell dives into the optic nerve from the
posterior retina. The increased intraocular pressure was an added stress on the genetically
susceptible organelle, leading to organelle failure. Moreover, his glaucomatous changes may
have been exacerbated by steroids that were given for the treatment of presumptive NMO. The
drastic deterioration of vision that appeared suddenly rather than gradually involving both eyes
may be a result of expedited RGC loss that typically occurs in end-stage disease. Given that the
mechanism for vison loss in both LHON and glaucoma involves loss of RGC, it is reasonable to
postulate that our patient’s sudden, acute, bilateral vision loss was due to synergistically,
deleterious effects of glaucoma and LHON.
The process by which raised intraocular pressure led to this patient’s vision loss is
multifactorial. Biologically, the precarious homeostatic state that prevails inside the RGCs
could have been perturbed by a buildup of pathogens related to LHON mutations. Increased
intraocular pressures may have exacerbated these perturbations by decreasing axoplasmic flow
or impairing the optic nerve head vascular supply at the critical transition region spanning the
lamina cribrosa [11]. In LHON, parvocellular RGCs (P-cells) are lost to a greater extent than
magnocellular RGCs (M-cells). The P-cells in papillomacular bundles possess a smaller cross-
section area compared to the relatively large M-cells. This anatomical fact may be responsible
for the susceptibility to increased pressure on axoplasmic flow, particularly in the high energy-
dependent unmyelinated segment of the optic nerve. Here, mitochondria are more affected in
the axons of RGCs due to raised intraocular pressure. These damaged mitochondria, in
combination with mutated mtDNA, will significantly reduce mitochondrial respiratory chain
efficiency and result in the formation and release of pro-apoptotic
cytochrome c molecules [12]. The final result is sudden, acute, non-progressive vision loss, as
seen in our patient.
Conclusions
LHON is a multifactorial disease primarily associated with mtDNA mutations; however, these
mutations are not sufficient alone to result in loss of sight. Secondary factors likely contributed
to LHON conversion to symptomatic disease. LHON is a difficult disease to diagnose. Its
presentation may mimic numerous other disorders such as NMO, isolated optic neuritis, and
sarcoidosis. Making the diagnosis requires a high clinical suspicion in the appropriate clinical
setting. It requires multiple resources in equipment and manpower for diagnosis. Identification
of specific mutations in the mtDNA is the gold standard for diagnosis. Unfortunately, there are
no current FDA-approved medications for the disease. Therefore, LHON patients need to be
provided with supportive therapy. This case report postulates a possible trigger leading to
symptomatic LHON and adds to the growing body of literature on LHON.
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